T5	Subject 36 47	15 patients
T6	Effect 64 102	acute hemoglobinemia or hemoglobinuria
T8	Treatment 113 124	anti-D IGIV
T9	Treat-Disorder 144 177	ITP or secondary thrombocytopenia
T10	Population 36 38	15
T11	Drug 113 124	anti-D IGIV
T12	Route 125 139	administration
T7	Adverse_event 103 112	following
E1	Adverse_event:T7